Table 1

Conditional 5-year relative survival estimates, by type of cancer and number of years since diagnosis, for patients aged 15–89 years at diagnosis, NSW Australia 1998-2006
Type of cancer Number of patients Estimated conditional 5-year relativesurvival (95% confidence intervals)
At diagnosis 1 year after diagnosis 3 years after diagnosis 5 years after diagnosis 10 years after diagnosis
Stomach 5,193 28.5 51.3 79.4 91.0 95.0
(27.2-29.8) (48.8-53.8) (76.2-82.6) (87.6-94.3) (91.0-98.9)
Colorectum 35,455 65.0 75.5 86.8 93.2 98.8
(64.4-65.7) (74.8-76.3) (86.0-87.6) (92.3-94.0) (97.7-99.9)
Pancreas 5,213 5.6 21.9 64.3 81.8 94.7
(5.0-6.3) (19.2-24.7) (56.9-71.7) (73.8-89.9) (86.1-103.4)
Lung 23,027 13.9 32.6 63.9 75.5 84.8
(13.4-14.4) (31.4-33.8) (61.8-66.1) (73.0-78.0) (81.5-88.1)
Melanoma 27,888 92.6 93.8 95.9 97.3 99.0
(92.1-93.1) (93.2-94.3) (95.3-96.4) (96.7-97.9) (98.4-99.6)
Breast (females) 36,585 88.6 88.8 90.4 91.6 93.3
(88.2-89.0) (88.3-89.2) (89.8-90.9) (91.0-92.1) (92.6-94.1)
Cervix 2,368 73.2 81.4 90.7 95.1 95.3
(71.4-75.0) (79.3-83.5) (89.0-92.4) (93.7-96.6) (93.9-96.8)
Prostate 39,851 90.2 90.7 91.2 90.0 89.6
(89.6-90.7) (90.0-91.3) (90.4-92.0) (89.1-90.9) (87.5-91.6)
Kidney 6,940 64.0 78.1 87.2 89.6 88.8
(62.7-65.4) (76.4-79.9) (85.5-89.0) (87.7-91.4) (86.1-91.4)
Bladder 6,154 62.5 75.1 86.0 89.8 91.5
(61.0-64.0) (73.2-77.1) (83.9-88.0) (87.7-92.0) (89.1-94.0)
Thyroid 4,508 96.0 98.7 98.8 98.9 98.3
(95.1-96.8) (97.7-99.6) (97.9-99.6) (98.0-99.9) (97.0-99.6)

Yu et al.

Yu et al. BMC Cancer 2012 12:460   doi:10.1186/1471-2407-12-460

Open Data